RALLYBIO CORP
Profile
Company Names
RALLYBIO CORP
RALLYBIO HOLDINGS, LLC
Addresses
234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT 06510
400 FARMINGTON AVENUE, SUITE R2818, FARMINGTON, CT 06032
Phone Numbers
203-859-3820
203-859-3821
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, OTHER HEALTH CARE
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$157,804,964.00
Number of Funding Rounds:
3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-04-10
$6,600,000.00
$6,600,000.00
$0.00
Equity
2
2020-03-27
$145,204,965.00
$145,204,965.00
$0.00
Equity
1
2018-04-20
$5,999,999.00
$5,999,999.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROB
HOPFNER
DIRECTOR
ROBERT
HOPFNER
DIRECTOR
RON
HUNT
DIRECTOR
RONALD
M.
HUNT
DIRECTOR
KUSH
PARMAR
DIRECTOR
KUSH
M.
PARMAR
DIRECTOR
KETAN
PATEL
DIRECTOR
INTELLEFLEX CORP
| SHOPWELL SOLUTIONS, INC.
| ACLARIS THERAPEUTICS, INC.
| RAINMAKER HOLDINGS II, LLC
| IVENIX, INC.
| GENOA PHARMACEUTICALS, INC.
| NFLECTION THERAPEUTICS, INC.
| MENLO THERAPEUTICS, INC.
| AMPHORA MEDICAL, INC.
| FOREST CITY REALTY TRUST, INC.
| AZAD ALLIANCE 2019 LLC
| AVALYN PHARMA INC.
| RALLYBIO HOLDINGS, LLC
| REDIRECT HEALTH, LLC
| FOREST CITY ENTERPRISES, L.P.
| AVIVOMED INC.
| ABK BIOMEDICAL INC
| FC 1275 NJ MEMBER LLC
| FC TOD MF II HOLDINGS LLC
| FC TOD BTR HOLDINGS I LLC
| COMANCHE BIOPHARMA CORP.
| LOS ANGELES BIOSCIENCES, INC.
| RAINMAKER CAPITAL LLC
TIM
SHANNON
DIRECTOR
NOVIRA THERAPEUTICS, INC.
| ARVINAS, INC.
| CIVITAS THERAPEUTICS, INC.
| CYTOMX THERAPEUTICS, INC.
| VIVACE THERAPEUTICS, INC.
| SPYRYX BIOSCIENCES, INC.
| ARVINAS HOLDING COMPANY, LLC
| NEXTCURE, INC.
| HALDA THERAPEUTICS, LLC
| RALLYBIO HOLDINGS, LLC
| CAPITAL INTEGRATION SYSTEMS LLC
| AER THERAPEUTICS, INC.
PAULA
SOTEROPOULOS
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-04-10
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#

